Results 151 to 160 of about 4,071 (233)

Fluocinolone acetonide implant (FAci) one month after dexamethasone implant (DEXi) for chronic diabetic macular edema: 1-year results.

Journal Francais d'Ophtalmologie
Q. Lampin, J. Poret, M. Gherras, B. Jany, T.H.C. Tran   +4 more
semanticscholar   +1 more source

Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant [PDF]

Current Medical Research and Opinion, 2017
openaire   +2 more sources

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema. [PDF]

Ophthalmol Ther, 2019
Eaton A, Koh SS, Jimenez J, Riemann CD.
europepmc   +1 more source

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies. [PDF]

BMC Health Serv Res, 2019
Pochopien M, Beiderbeck A, McEwan P, Zur R, Toumi M, Aballéa S.   +5 more
europepmc   +1 more source

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy. [PDF]

Eye (Lond), 2017
Meireles A, Goldsmith C, El-Ghrably I, Erginay A, Habib M, Pessoa B, Coelho J, Patel T, Tadayoni R, Massin P, Atorf J, Augustin AJ.   +11 more
europepmc   +1 more source

Comment on the Review: Clarifying Steroid-Associated Glaucoma-From Association to an Actionable Closed-Loop [Letter]. [PDF]

J Inflamm Res
Xu L, Chen X, Liu G.
europepmc   +1 more source

Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response. [PDF]

J Vitreoretin Dis
Bello NR, Wang RC, Boss J, Singer M, Hopkins S, Billawala K, Henry CR, Mammo DA.   +7 more
europepmc   +1 more source

Impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes. [PDF]

Eye (Lond)
Kozak I, Khoramnia R, Taylor SR, Chakravarthy U, ILUVIEN Registry Safety Study (IRISS) Investigators Group.   +4 more
europepmc   +1 more source

Efficacy and safety of fluocinolone acetonide intravitreal implant (0.2 µg/day) in patients with post-surgical inflammation associated with macular edema: a case series study. [PDF]

J Ophthalmic Inflamm Infect
Madeira M, Cabugueira A, Urbano H, Cordeiro M, Guedes M.   +4 more
europepmc   +1 more source

Efficacy and safety of multiple fluocinolone acetonide implants in diabetic macular oedema: comparison between first and second intravitreal injections. [PDF]

Eye (Lond)
Serrar Y, Sejournet L, Thomeret V, Dot C, Bonnin S, Soler V, Rosier L, Matonti F, Ghazaryan M, Mathis T, Kodjikian L.   +10 more
europepmc   +1 more source